Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Guazzi, Paolo ^a   Goitre, Luca ^b   Ferro, Elisa ^a   Cutano, Valentina ^b   Martino, Chiara ^b   Trabalzini, Lorenza ^a   Retta, Saverio Francesco ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KRIT1; PROTEIN ND1 L; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL NUCLEUS; CYTOPLASM; HOMEOSTASIS; HUMANS; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; REACTIVE OXYGEN SPECIES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84866128571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044705     Document Type: Article

References (43)

1. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D, (2001) Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71: 188-192.
2. Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA, (2004) Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 55: 1-16; discussion 16-17.
3. Leblanc GG, Golanov E, Awad IA, Young WL, (2009) Biology of vascular malformations of the brain. Stroke 40: e694-702.
4. Yadla S, Jabbour PM, Shenkar R, Shi C, Campbell PG, et al. (2010) Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus 29: E4.
5. Felbor U, Sure U, Grimm T, Bertalanffy H, (2006) Genetics of cerebral cavernous angioma. Zentralbl Neurochir 67: 110-116.
6. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E, (2007) Genetics of cavernous angiomas. Lancet Neurol 6: 237-244.
7. Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E, (2010) Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. Febs J 277: 1070-1075.
8. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY, (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131: 1437-1448.
9. Goitre L, Balzac F, Degani S, Degan P, Marchi S, et al. (2010) KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS One 5: e11786.
10. Faurobert E, Albiges-Rizo C, (2010) Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. Febs J 277: 1084-1096.
11. Francalanci F, Avolio M, De Luca E, Longo D, Menchise V, et al. (2009) Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp Cell Res 315: 285-303.
12. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA, (1997) Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15: 1043-1049.
13. Zawistowski JS, Serebriiskii IG, Lee MF, Golemis EA, Marchuk DA, (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11: 389-396.
14. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, et al. (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14: 2521-2531.
15. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC, (2001) Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10: 2953-2960.
16. Zhang J, Rigamonti D, Dietz HC, Clatterbuck RE, (2007) Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 60: 353-359; discussion 359.
17. Balzac F, Avolio M, Degani S, Kaverina I, Torti M, et al. (2005) E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. J Cell Sci 118: 4765-4783.
18. Retta SF, Balzac F, Avolio M, (2006) Rap1: a turnabout for the crosstalk between cadherins and integrins. Eur J Cell Biol 85: 283-293.
19. Pearson MA, Reczek D, Bretscher A, Karplus PA, (2000) Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101: 259-270.
20. Glading A, Han J, Stockton RA, Ginsberg MH, (2007) KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179: 247-254.
21. Glading AJ, Ginsberg MH, (2010) Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis Model Mech 3: 73-83.
22. Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, et al. (2010) Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285: 11760-11764.
23. Stockton RA, Shenkar R, Awad IA, Ginsberg MH, (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207: 881-896.
24. Retta SF, Avolio M, Francalanci F, Procida S, Balzac F, et al. (2004) Identification of Krit1B: a novel alternative splicing isoform of cerebral cavernous malformation gene-1. Gene 325: 63-78.
25. Sedgwick SG, Smerdon SJ, (1999) The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem Sci 24: 311-316.
26. Sasagawa K, Matsudo Y, Kang M, Fujimura L, Iitsuka Y, et al. (2002) Identification of Nd1, a novel murine kelch family protein, involved in stabilization of actin filaments. J Biol Chem 277: 44140-44146.
27. Li B, Fields S, (1993) Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. Faseb J 7: 957-963.
28. Kang M, Matsudo Y, Sasagawa K, Tokuhisa T, Hatano M, (2001) Nd1, a novel murine Kelch family protein, may play the role of a housekeeping gene. Biochim Biophys Acta 1519: 167-174.
29. Fujimura L, Matsudo Y, Kang M, Takamori Y, Tokuhisa T, et al. (2004) Protective role of Nd1 in doxorubicin-induced cardiotoxicity. Cardiovasc Res 64: 315-321.
30. Matsudo Y, Takamori Y, Fujimura L, Nishio S, Sasagawa K, et al. (2006) Overexpression of Nd1, a novel Kelch family protein, in the heart of transgenic mice protects against doxorubicin-induced cardiomyopathy. Transgenic Res 15: 573-581.
31. Ohta Y, Fujimura L, Nishio S, Arima M, Sakamoto A, et al. (2010) A kelch family protein Nd1-L functions as a metastasis suppressor in cancer cells via Rho family proteins mediated mechanism. Int J Oncol 36: 427-434.
32. Wolff T, O'Neill RE, Palese P, (1998) NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol 72: 7170-7180.
33. Perconti G, Ferro A, Amato F, Rubino P, Randazzo D, et al. (2007) The kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control. Biochim Biophys Acta 1773: 1774-1785.
34. Adams J, Kelso R, Cooley L, (2000) The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 10: 17-24.
35. Bardwell VJ, Treisman R, (1994) The POZ domain: a conserved protein-protein interaction motif. Genes Dev 8: 1664-1677.
36. Stogios PJ, Prive GG, (2004) The BACK domain in BTB-kelch proteins. Trends Biochem Sci 29: 634-637.
37. Gingras AR, Ziegler WH, Bobkov AA, Joyce MG, Fasci D, et al. (2009) Structural determinants of integrin binding to the talin rod. J Biol Chem 284: 8866-8876.
38. Goult BT, Bate N, Anthis NJ, Wegener KL, Gingras AR, et al. (2009) The structure of an interdomain complex that regulates talin activity. J Biol Chem 284: 15097-15106.
39. Calderwood DA, (2004) Talin controls integrin activation. Biochem Soc Trans 32: 434-437.
40. Calderwood DA, Tai V, Di Paolo G, De Camilli P, Ginsberg MH, (2004) Competition for talin results in trans-dominant inhibition of integrin activation. J Biol Chem 279: 28889-28895.
41. Critchley DR, Gingras AR, (2008) Talin at a glance. J Cell Sci 121: 1345-1347.
42. Ziegler WH, Gingras AR, Critchley DR, Emsley J, (2008) Integrin connections to the cytoskeleton through talin and vinculin. Biochem Soc Trans 36: 235-239.
43. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.